Clinical trial
Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed…
NCT00098774 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00098774 |
|---|---|
| Title | Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma |
| Official title | Intensive Chemotherapy And Immunotherapy In Patients With Newly Diagnosed Primary CNS Lymphoma |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, rituximab, cytarabine, etoposide, leucovorin calcium, methotrexate, temozolomide |
| Enrollment | 47 |
| Start date | Oct 1, 2004 |
| Primary completion | Jan 1, 2010 |
| Completion | Sep 1, 2014 |
| First posted | Dec 9, 2004 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: